Results 101 to 110 of about 6,377 (212)

Dermatologic and otorhinolaryngologic manifestations in leishmaniasis

open access: yesInternational Archives of Otorhinolaryngology, 2011
Introduction: Leishmaniasis is an extremely important parasitic disease as regards epidemiology, and, in such a disease, man is an occasional host to the Leishmania protozoon.
Mota, Luiz Alberto Alves   +1 more
doaj  

Pentavalent Antimonials Combined with Other Therapeutic Alternatives for the Treatment of Cutaneous and Mucocutaneous Leishmaniasis: A Systematic Review

open access: yesDermatology Research and Practice, 2018
The first choice drugs for the treatment of cutaneous and mucocutaneous leishmaniasis are pentavalent antimonials, sodium stibogluconate, or meglumine antimoniate.
Taisa Rocha Navasconi Berbert   +10 more
doaj   +1 more source

The molecular epidemiology and phylogeography of Trypanosoma cruzi and parallel research on Leishmania: looking back and to the future. [PDF]

open access: yes, 2009
Trypanosoma cruzi is the protozoan agent of Chagas disease, and the most important parasitic disease in Latin America. Protozoa of the genus Leishmania are global agents of visceral and cutaneous leishmaniasis, fatal and disfiguring diseases.
Fitpatrick, S.   +15 more
core   +1 more source

Leishmaniasis in humans and small animals: Updates and insights through a one health

open access: yesLetters in Animal Biology
Leishmaniasis is neglected infectious disease caused by a type of microscopic parasite called Leishmania spp. This disease can affect both humans and animals, as well as sandflies.
Amirhossein Badkoubi   +6 more
doaj   +1 more source

Clinical and therapeutic characteristics of 206 patients with mucocutaneous leishmaniasis. INI FIOCRUZ, 2014.

open access: yes, 2014
n-valid numbers, Md - median, IQR - interquartile range.Clinical and therapeutic characteristics of 206 patients with mucocutaneous leishmaniasis. INI FIOCRUZ, 2014.
Cláudia Maria Valete-Rosalino (3173487)   +10 more
core   +1 more source

Leishmania major: genetic heterogeneity of Iranian isolates by single-strand conformation polymorphism and sequence analysis of ribosomal DNA internal transcribed spacer.

open access: yes, 2006
Protozoan parasites of Leishmania major are the causative agents of cutaneous leishmaniasis in different parts of Iran. We applied PCR-based methods to analyze L.
Mauricio, Isabel L   +6 more
core   +1 more source

Leishmaniose tegumentar americana na Ilha Grande, Rio de Janeiro: IV. reservatórios doméstios

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 1981
Durante um surto de Leishmaniose Tegumemar Americana (LTA) na Praia Vermelha, Ilha Grande, município de Angra dos Reis, RJ, durante o ano de 1976, os autores examinaram 64 animais domésticos sendo 38 cães e 28 gatos. Nos 38 cães examinados, constatou-se,
Nelson A. de Araújo Filho   +2 more
doaj  

Use of itraconazole in the treatment of mucocutaneous leishmaniasis: A pilot study

open access: yes, 2000
Objectives: Mucocutaneous leishmaniasis is widely distributed in Brazil, with Leishmania (Viannia) braziliensis being the major etiologic agent. The currently recommended therapy is limited by its parenteral use, high toxicity, and variable efficacy.
Nicodemo, Antônio C.   +7 more
core   +1 more source

Mucocutaneous leishmaniasis: report of a case with massive involvement of nasal, pharyngeal and laryngeal mucosa

open access: yes, 2006
Mucocutaneous leishmaniasis: report of a case with massive involvement of nasal, pharyngeal and laryngeal mucosa F. Di Lella1, , , V. Vincenti1, D. Zennaro2, A. Afeltra2, A. Baldi3, D. Giordano1, E. Pasanisi1, A. Bacciu1, S. Bacciu1, G.
BACCIU A   +15 more
core   +1 more source

Leishmania isoenzyme polymorphisms in Ecuador: Relationships with geographic distribution and clinical presentation

open access: yes, 2006
Background: Determinants of the clinical presentation of the leishmaniases are poorly understood but Leishmania species and strain differences are important.
Cooper Philip J   +48 more
core   +1 more source

Home - About - Disclaimer - Privacy